Cite Filings / SLS / 0000950170-25-072815

Feed Companies Filings Check

Sign in

SCHEDULE 13G

Statement of Beneficial Ownership

SELLAS Life Sciences Group, Inc. Filed 2025-05-15 Acc 0000950170-25-072815

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2025-07-29 SCHEDULE 13G Statement of Beneficial Ownership
2025-05-22 4 Director bought 20,000 shares at $1.80 ($36,000)
2025-05-15 SCHEDULE 13G Statement of Beneficial Ownership
2025-05-13 8-K Results of operations
2025-05-13 10-Q Quarterly Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…